Improving Heart Function (iHF)
Improving Heart Function (iHF) is an innovative, transdisciplinary educational platform open to all healthcare professionals committed to the optimal management of heart failure patients.
Our mission is to optimise patient outcomes by identifying and addressing unmet needs in heart failure management and by enhancing the collaboration between pharmaceuticals and medical devices.
How should we manage heart failure treatment before and after revascularisation in case of CCS?
Aortic stenosis with cardiac amyloidosis: much more than just another TAVI patient at iHFCourse 2026
Should atrial fibrillation ablation be the 5th pillar in HF management with atrial fibrillation?
What is the role of mechanical circulatory support in decompensated heart failure?
Chronic heart failure: in which clinical scenarios interventions can play a role?
Novel fast-track strategies to GDMT optimisation in HF patients with functional mitral regurgitation
Why does combining oral therapy and devices matter in managing refractory heart failure?
Refractory heart failure: combining oral therapy and device is key
Sudden cardiac arrest and WCD therapies: large-scale data from 19 000 high-risk patients – HFA 2025
When you think that STEMI is all about primary PCI - A clinical case
New onset of heart failure and reduced ventricular ejection fraction - A clinical case
DAPA-TAVI trial results: dapaglifozin reduces heart failure and mortality after TAVI
Trans-disciplinary innovative drugs and device solutions for heart failure care
An interview with Emanuele Barbato - Introducing the Improving Heart Function (iHF) initiative
An interview with Giuseppe Rosano - Introducing the Improving Heart Function (iHF) initiative